Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16680149rdf:typepubmed:Citationlld:pubmed
pubmed-article:16680149lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:16680149lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:16680149lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:16680149lifeskim:mentionsumls-concept:C0443211lld:lifeskim
pubmed-article:16680149lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:16680149pubmed:issue6lld:pubmed
pubmed-article:16680149pubmed:dateCreated2006-6-8lld:pubmed
pubmed-article:16680149pubmed:abstractTextTumor-cell apoptosis is the basis of many cancer therapies, and tumor-specific T cells are the principal effectors of successful antitumor immunotherapies. Here we show that induction of tumor-cell apoptosis by an agonistic monoclonal antibody to DR5, the apoptosis-inducing receptor for TNF-related apoptosis-inducing ligand (TRAIL), combined with T-cell activation by agonistic monoclonal antibodies to the costimulatory molecules CD40 and CD137, potently and rapidly stimulated tumor-specific effector CD8+ T cells capable of eradicating preestablished tumors. Primary fibrosarcomas initiated with the carcinogen 3-methylcholanthrene (MCA), multiorgan metastases and a primary tumor containing as many as 90% tumor cells resistant to DR5-specific monoclonal antibody were rejected without apparent toxicity or induction of autoimmunity. This combination therapy of three monoclonal antibodies (trimAb) rapidly induced tumor-specific CD8+ T cells producing interferon (IFN)-gamma in the tumor-draining lymph node, consistent with a crucial requirement for CD8+ T cells and IFN-gamma in the tumor rejection process. These results in mice indicate that a rational monoclonal antibody-based therapy that both causes tumor-cell apoptosis through DR5 and activates T cells may be an effective strategy for cancer immunotherapy in humans.lld:pubmed
pubmed-article:16680149pubmed:languageenglld:pubmed
pubmed-article:16680149pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16680149pubmed:citationSubsetIMlld:pubmed
pubmed-article:16680149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16680149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16680149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16680149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16680149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16680149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16680149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16680149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16680149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16680149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16680149pubmed:statusMEDLINElld:pubmed
pubmed-article:16680149pubmed:monthJunlld:pubmed
pubmed-article:16680149pubmed:issn1078-8956lld:pubmed
pubmed-article:16680149pubmed:authorpubmed-author:TakedaKazuyos...lld:pubmed
pubmed-article:16680149pubmed:authorpubmed-author:YagitaHideoHlld:pubmed
pubmed-article:16680149pubmed:authorpubmed-author:SmythMark JMJlld:pubmed
pubmed-article:16680149pubmed:authorpubmed-author:KojimaYukoYlld:pubmed
pubmed-article:16680149pubmed:authorpubmed-author:OkumuraKoKlld:pubmed
pubmed-article:16680149pubmed:authorpubmed-author:GejyoFumitake...lld:pubmed
pubmed-article:16680149pubmed:authorpubmed-author:AkibaHisayaHlld:pubmed
pubmed-article:16680149pubmed:authorpubmed-author:MittlerRobert...lld:pubmed
pubmed-article:16680149pubmed:authorpubmed-author:YoshizawaHiro...lld:pubmed
pubmed-article:16680149pubmed:authorpubmed-author:UnoTomoyasuTlld:pubmed
pubmed-article:16680149pubmed:issnTypePrintlld:pubmed
pubmed-article:16680149pubmed:volume12lld:pubmed
pubmed-article:16680149pubmed:ownerNLMlld:pubmed
pubmed-article:16680149pubmed:authorsCompleteYlld:pubmed
pubmed-article:16680149pubmed:pagination693-8lld:pubmed
pubmed-article:16680149pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:meshHeadingpubmed-meshheading:16680149...lld:pubmed
pubmed-article:16680149pubmed:year2006lld:pubmed
pubmed-article:16680149pubmed:articleTitleEradication of established tumors in mice by a combination antibody-based therapy.lld:pubmed
pubmed-article:16680149pubmed:affiliationDepartment of Immunology, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan.lld:pubmed
pubmed-article:16680149pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16680149pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16680149lld:pubmed